News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,670 Results
Type
Article (47356)
Company Profile (340)
Press Release (705965)
Multimedia
Podcasts (112)
Webinars (20)
Section
Business (213285)
Career Advice (2145)
Deals (36663)
Drug Delivery (113)
Drug Development (83045)
Employer Resources (178)
FDA (17085)
Job Trends (15542)
News (359218)
Policy (33966)
Tag
Academia (2748)
Accelerated approval (28)
Adcomms (28)
Allergies (130)
Alliances (52910)
ALS (167)
Alzheimer's disease (1678)
Antibody-drug conjugate (ADC) (285)
Approvals (17294)
Artificial intelligence (506)
Autoimmune disease (121)
Automation (33)
Bankruptcy (369)
Best Places to Work (11984)
BIOSECURE Act (21)
Biosimilars (180)
Biotechnology (221)
Bladder cancer (150)
Brain cancer (53)
Breast cancer (608)
Cancer (4563)
Cardiovascular disease (376)
Career advice (1810)
Career pathing (35)
CAR-T (280)
CDC (45)
Celiac Disease (1)
Cell therapy (724)
Cervical cancer (35)
Clinical research (70284)
Collaboration (1569)
Company closure (4)
Compensation (1072)
Complete response letters (50)
COVID-19 (2817)
CRISPR (91)
C-suite (719)
Cystic fibrosis (142)
Data (5843)
Decentralized trials (2)
Denatured (45)
Depression (118)
Diabetes (470)
Diagnostics (6983)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (237)
Drug pricing (171)
Drug shortages (30)
Duchenne muscular dystrophy (218)
Earnings (91675)
Editorial (53)
Employer branding (23)
Employer resources (157)
Events (121994)
Executive appointments (977)
FDA (19972)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1405)
Gene editing (198)
Generative AI (45)
Gene therapy (580)
GLP-1 (949)
Government (4786)
Grass and pollen (7)
Guidances (378)
Healthcare (19676)
HIV (54)
Huntington's disease (39)
IgA nephropathy (75)
Immunology and inflammation (236)
Immuno-oncology (40)
Indications (79)
Infectious disease (3070)
Inflammatory bowel disease (187)
Inflation Reduction Act (13)
Influenza (109)
Intellectual property (225)
Interviews (331)
IPO (17000)
IRA (50)
Job creations (3928)
Job search strategy (1525)
Kidney cancer (15)
Labor market (80)
Layoffs (563)
Leadership (31)
Legal (8297)
Liver cancer (91)
Longevity (12)
Lung cancer (622)
Lymphoma (360)
Machine learning (39)
Management (63)
Manufacturing (712)
MASH (156)
Medical device (14480)
Medtech (14520)
Mergers & acquisitions (20656)
Metabolic disorders (1174)
Multiple sclerosis (146)
NASH (17)
Neurodegenerative disease (292)
Neuropsychiatric disorders (73)
Neuroscience (2812)
NextGen: Class of 2025 (6886)
Non-profit (4674)
Now hiring (61)
Obesity (541)
Opinion (271)
Ovarian cancer (153)
Pain (179)
Pancreatic cancer (205)
Parkinson's disease (263)
Partnered (32)
Patents (467)
Patient recruitment (420)
Peanut (57)
People (61188)
Pharmaceutical (73)
Pharmacy benefit managers (26)
Phase I (22032)
Phase II (30889)
Phase III (22989)
Pipeline (4067)
Policy (276)
Postmarket research (2623)
Preclinical (9467)
Press Release (71)
Prostate cancer (223)
Psychedelics (43)
Radiopharmaceuticals (287)
Rare diseases (746)
Real estate (6333)
Recruiting (70)
Regulatory (24926)
Reports (51)
Research institute (2544)
Resumes & cover letters (371)
Rett syndrome (23)
RNA editing (15)
RSV (75)
Schizophrenia (142)
Series A (234)
Series B (173)
Service/supplier (14)
Sickle cell disease (96)
Special edition (20)
Spinal muscular atrophy (154)
Sponsored (42)
Startups (3900)
State (2)
Stomach cancer (16)
Supply chain (100)
Tariffs (80)
The Weekly (65)
Vaccines (1006)
Venture capital (81)
Weight loss (355)
Women's health (75)
Worklife (17)
Date
Today (10)
Last 7 days (128)
Last 30 days (1746)
Last 365 days (31086)
2026 (26)
2025 (31085)
2024 (36330)
2023 (41281)
2022 (52525)
2021 (57140)
2020 (55819)
2019 (48595)
2018 (36614)
2017 (33768)
2016 (33440)
2015 (39617)
2014 (33328)
2013 (28467)
2012 (30634)
2011 (31263)
2010 (29259)
Location
Africa (800)
Alabama (80)
Alaska (7)
Arizona (305)
Arkansas (14)
Asia (42236)
Australia (7051)
California (10699)
Canada (3138)
China (1026)
Colorado (449)
Connecticut (464)
Delaware (323)
Europe (93410)
Florida (1576)
Georgia (345)
Hawaii (2)
Idaho (64)
Illinois (836)
India (56)
Indiana (505)
Iowa (21)
Japan (393)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (70)
Maryland (1335)
Massachusetts (7795)
Michigan (329)
Minnesota (612)
Mississippi (6)
Missouri (132)
Montana (33)
Nebraska (27)
Nevada (115)
New Hampshire (80)
New Jersey (2895)
New Mexico (30)
New York (2845)
North Carolina (1425)
North Dakota (10)
Northern California (5115)
Ohio (318)
Oklahoma (21)
Oregon (41)
Pennsylvania (2183)
Puerto Rico (20)
Rhode Island (46)
South America (1172)
South Carolina (61)
South Dakota (1)
Southern California (4147)
Tennessee (167)
Texas (1664)
United States (38461)
Utah (322)
Vermont (1)
Virginia (248)
Washington D.C. (79)
Washington State (890)
West Virginia (4)
Wisconsin (101)
Wyoming (2)
753,670 Results for "smiths detection formerly barringer technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient Formerly on Yorvipath
The death occurred in a patient who had a complex medical background and who was being managed with several drugs, according to RBC Capital.
October 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Medical Care Technologies Inc. Unveils Breakthrough AI for Early Melanoma Detection
September 18, 2025
·
1 min read
Press Releases
Medical Care Technologies Inc. Launches AI Platform for Early Basal Cell Carcinoma Detection
September 22, 2025
·
1 min read
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
FDA
New Approach Methodologies: Redefining Animal Testing Alternatives
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Stacey Adam, PhD, Vice President of Science Partnerships at the Foundation for the National Institutes of Health and Patrick Smith, Senior Vice President, Translational Science at Certara, to discuss the latest regulatory news and the future for new approach methologies (NAMs) development.
December 4, 2025
·
1 min read
·
BioSpace Insights
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
In this episode of Denatured, Jennifer Smith-Parker speaks to Kenneth Galbraith,
CEO of Zymeworks and Josh Smiley, president and COO of Zai Lab, about how renewed confidence is driving biotech entering 2026.
December 18, 2025
·
1 min read
·
BioSpace Insights
IN PARTNERSHIP WITH ANAPTYSBIO
Beyond the Gluten-Free Diet: A New Era in Celiac Disease Treatment
In this episode of Denatured presented by AnaptysBio, Jennifer Smith-Parker speaks to Dr. Joe Murray, Mayo Clinic; Marilyn Geller, the Celiac Disease Foundation; and Dr. Paul Lizzul, AnaptysBio, about the challenges and opportunities facing celiac disease treatment.
December 11, 2025
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Detect-ION Launches Collaborative Project to Develop Breath-Based Diagnostics for Pneumonia-Causing Pathogens
December 16, 2025
·
4 min read
Press Releases
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
December 17, 2025
·
3 min read
Press Releases
Quetzal Therapeutics Appoints Todd Smith as Board Member
November 13, 2025
·
1 min read
1 of 75,367
Next
